Fig. 8From: Myeloid leukemia-derived galectin-1 downregulates CAR expression to hinder cytotoxicity of CAR T cellsGalectin-1-specific inhibitory peptide is ineffective in vivo A, The CD33 CAR T cells was sorted and purified by FACS. B, Schematic of the acute myeloid leukemia model. C, Representative bioluminescence images of tumor growth. D, T cells in peripheral blood 10 and 20 days after CAR T infusion. Each dot represents one mouse, n = 3 mice per groupBack to article page